Analyzing Valion Bio, Inc. Common Stock (NASDAQ:VBIO) & CVR Medical (OTCMKTS:CRRVF)

Valion Bio, Inc. Common Stock (NASDAQ:VBIO) and CVR Medical (OTCMKTS:CRRVF) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, dividends, risk and earnings.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Valion Bio, Inc. Common Stock and CVR Medical, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Valion Bio, Inc. Common Stock	1	0	0	0	1.00
CVR Medical	0	0	0	0	0.00

Given CVR Medical’s higher probable upside, analysts clearly believe CVR Medical is more favorable than Valion Bio, Inc. Common Stock.

Volatility and Risk

Valion Bio, Inc. Common Stock has a beta of 1.79, indicating that its share price is 79% more volatile than the S&P 500. Comparatively, CVR Medical has a beta of 31.82, indicating that its share price is 3,082% more volatile than the S&P 500.

Earnings & Valuation

This table compares Valion Bio, Inc. Common Stock and CVR Medical”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Valion Bio, Inc. Common Stock	$780,000.00	2.65	-$8.88 million	($6.68)	-0.10
CVR Medical	N/A	N/A	N/A	($0.02)	N/A

CVR Medical has lower revenue, but higher earnings than Valion Bio, Inc. Common Stock. Valion Bio, Inc. Common Stock is trading at a lower price-to-earnings ratio than CVR Medical, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

4.3% of Valion Bio, Inc. Common Stock shares are held by institutional investors. 14.5% of Valion Bio, Inc. Common Stock shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Valion Bio, Inc. Common Stock and CVR Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Valion Bio, Inc. Common Stock	N/A	-138.10%	-63.67%
CVR Medical	N/A	N/A	N/A

Summary

CVR Medical beats Valion Bio, Inc. Common Stock on 5 of the 9 factors compared between the two stocks.

About Valion Bio, Inc. Common Stock

Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

About CVR Medical

CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.